NNM Securities
ABOUT US
SERVICES
EQUITY
COMMODITY
CURRENCY
DERIVATIVES
MUTUAL FUND
ADVISORY
FINANCING
MARKET INFO
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
RESEARCH
CONTACT US
LOGIN
Gallery
Open Account Meon
Open Account
Partner Us
Downloads
COMPANY
EQUITY
DERIVATIVES
IPO
MUTUAL FUNDS
CURRENCY
COMMODITIES
more from company profile
General
Smart Quotes
Company Information
Comparison
Company News
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Financial Ratios
Cash Flow
Holdings
Share Holdings
MF Holdings
Digital Reports
Corp Actions
Board Meeting
Book Closure
Bonus Issues
Dividend Details
Price Info
Share Price
Historical Volume
Deliverable Volume
Bulk Deals
Block Deals
Price Charts
Home
Market Info
Company Profile
Quarterly Results
Quarterly Results
GLENMARK PHARMACEUTICALS LTD.
NSE :
GLENMARK
BSE :
532296
ISIN CODE :
INE935A01035
Industry :
Pharmaceuticals & Drugs
House :
Glenmark
BSE
1071.65
-8.4 (-0.78 %)
PREV CLOSE (
)
1080.05
OPEN PRICE (
)
1092.60
BID PRICE (QTY)
0.00 (0)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
19082
TODAY'S LOW / HIGH (
)
1063.65
1098.00
52 WK LOW / HIGH (
)
520.1
1095.95
NSE
1071.10
-8.25 (-0.76 %)
PREV CLOSE(
)
1079.35
OPEN PRICE (
)
1090.00
BID PRICE (QTY)
1071.10 (494)
OFFER PRICE (QTY)
0.00 (0)
VOLUME
442802
TODAY'S LOW / HIGH(
)
1063.05
1098.00
52 WK LOW / HIGH (
)
520.1
1096
Consolidated
Standalone
Quarters
3
4
5
6
7
8
Rs.in Crore
Rs. in Million
GO
Dec2023
Sep2023
Jun2023
Mar2023
(
in Million)
Particulars
Dec 2023
Sep 2023
Jun 2023
Mar 2023
Audited / UnAudited
UnAudited
Audited
UnAudited
Audited
Net Sales
25067.02
32073.78
34016.03
33737.15
Total Expenditure
27153.50
27450.93
27703.89
27687.49
PBIDT (Excl OI)
-2086.48
4622.85
6312.14
6049.66
Other Income
454.10
16.97
208.72
-402.13
Operating Profit
-1632.38
4639.82
6520.86
5647.53
Interest
1343.44
1214.58
1120.04
1092.56
Exceptional Items
-767.24
-3254.23
-520.23
-7997.32
PBDT
-3743.06
171.01
4880.59
-3442.35
Depreciation
1470.75
1414.54
1546.52
1465.33
Profit Before Tax
-5213.81
-1243.53
3334.07
-4907.68
Tax
-718.01
559.46
1602.79
-876.31
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-4495.80
-1802.99
1731.28
-4031.37
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-3308.15
-615.62
1731.28
-4031.37
Minority Interest
-205.59
-203.83
-231.94
-251.66
Shares of Associates
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-3513.74
-819.45
1499.34
-4283.03
Equity Capital
282.17
282.17
282.17
282.17
Face Value (IN RS)
1.00
1.00
1.00
1.00
Reserves
NA
NA
NA
NA
Calculated EPS
-12.45
-2.90
5.31
-15.18
Calculated EPS (Annualised)
-49.81
-11.62
21.25
-60.72
No of Public Share Holdings
150550469.00
150550469.00
150550469.00
150550469.00
% of Public Share Holdings
53.35
53.35
53.35
53.35
NA
NA
NA
NA
PBIDTM% (Excl OI)
-8.32
14.41
18.56
17.93
PBIDTM%
-6.51
14.47
19.17
16.74
PBDTM%
-14.93
0.53
14.35
-10.20
PBTM%
-20.80
-3.88
9.80
-14.55
PATM%
-17.94
-5.62
5.09
-11.95
Notes
Notes
Notes
Notes
X